"The FDA, the USDA, CDC, all of them are controlled by giant for-profit corporations. 75% of the FDA funding doesn’t come from taxpayers. It comes from pharma. And pharma executives and consultants and lobbyists cycle in and out of these agencies. With President Trump’s backing, I’m going to change that. We’re going to staff these agencies with honest scientists and doctors who are free from industry funding. We’re going to make sure the decisions of consumers, doctors, and patients are informed by unbiased science. A sick child is the best thing for the pharmaceutical industry. When American children or adults are sick with a chronic condition, they’re put on medication for their entire life.
"Imagine what happens when Medicare starts paying for Ozempic which costs 1,500 dollars a month, and that’s being recommended for children as young as six over a condition, obesity, that is completely preventable and barely even existed a hundred years ago. Since 74% of Americans are obese, the cost if all of them took their Ozempic prescription is $3 trillion a year. This is a drug that has made Novo Nordisk, the biggest company in Europe – it’s a Danish company, and the Danish government does not recommend it. It recommends a change in diet to treat obesity, and exercise. In our country, the recommendation now is for Ozempic to children as young as age six. Novo Nordisk is the biggest company in Europe, and virtually its entire value is based upon its projections of what Ozempic is going to sell to America."
-- Robert F. Kennedy Jr., August 23, 2024
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”